Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company is headquartered in Waltham, Massachusetts. Show more

Location: 300 Fifth Avenue, Waltham, MA, 02451, United States | Website: https://crescentbiopharma.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

196.7M

52 Wk Range

$10.83 - $63.00

Previous Close

$11.72

Open

$11.86

Volume

42,060

Day Range

$11.59 - $11.92

Enterprise Value

54.89M

Cash

152.6M

Avg Qtr Burn

-6.269M

Insider Ownership

6.56%

Institutional Own.

77.39%

Qtr Updated

06/30/25